nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—ALB—lung cancer	0.242	1	CbGaD
Repaglinide—ALB—Gefitinib—lung cancer	0.061	0.133	CbGbCtD
Repaglinide—SLCO1B1—Irinotecan—lung cancer	0.0594	0.13	CbGbCtD
Repaglinide—ALB—Erlotinib—lung cancer	0.036	0.0787	CbGbCtD
Repaglinide—ALB—Irinotecan—lung cancer	0.0325	0.071	CbGbCtD
Repaglinide—SLCO1B1—Methotrexate—lung cancer	0.0315	0.0686	CbGbCtD
Repaglinide—CYP2C8—Erlotinib—lung cancer	0.0278	0.0608	CbGbCtD
Repaglinide—CYP2C8—Paclitaxel—lung cancer	0.0255	0.0556	CbGbCtD
Repaglinide—CYP3A4—Topotecan—lung cancer	0.0209	0.0456	CbGbCtD
Repaglinide—CYP2C8—Etoposide—lung cancer	0.0201	0.044	CbGbCtD
Repaglinide—CYP3A4—Gefitinib—lung cancer	0.0191	0.0417	CbGbCtD
Repaglinide—CYP3A4—Teniposide—lung cancer	0.0185	0.0404	CbGbCtD
Repaglinide—ALB—Methotrexate—lung cancer	0.0172	0.0376	CbGbCtD
Repaglinide—CYP3A4—Vinorelbine—lung cancer	0.0147	0.0321	CbGbCtD
Repaglinide—CYP3A4—Crizotinib—lung cancer	0.0117	0.0256	CbGbCtD
Repaglinide—CYP3A4—Erlotinib—lung cancer	0.0113	0.0247	CbGbCtD
Repaglinide—CYP3A4—Paclitaxel—lung cancer	0.0103	0.0226	CbGbCtD
Repaglinide—CYP3A4—Irinotecan—lung cancer	0.0102	0.0223	CbGbCtD
Repaglinide—CYP3A4—Vinblastine—lung cancer	0.00907	0.0198	CbGbCtD
Repaglinide—CYP3A4—Etoposide—lung cancer	0.00817	0.0178	CbGbCtD
Repaglinide—CYP3A4—Docetaxel—lung cancer	0.00748	0.0163	CbGbCtD
Repaglinide—CYP3A4—Doxorubicin—lung cancer	0.00557	0.0122	CbGbCtD
Repaglinide—PPARG—Irinotecan—Topotecan—lung cancer	0.00178	0.33	CbGdCrCtD
Repaglinide—PPARG—Topotecan—Irinotecan—lung cancer	0.00148	0.274	CbGdCrCtD
Repaglinide—PPARG—Etoposide—Teniposide—lung cancer	0.00147	0.272	CbGdCrCtD
Repaglinide—KCNJ11—mammary gland—lung cancer	0.0011	0.153	CbGeAlD
Repaglinide—ABCC8—mammary gland—lung cancer	0.00102	0.141	CbGeAlD
Repaglinide—SLCO1B1—mammary gland—lung cancer	0.000899	0.125	CbGeAlD
Repaglinide—PPARG—mammary gland—lung cancer	0.000775	0.108	CbGeAlD
Repaglinide—ALB—mammary gland—lung cancer	0.000727	0.101	CbGeAlD
Repaglinide—PPARG—Teniposide—Etoposide—lung cancer	0.000666	0.124	CbGdCrCtD
Repaglinide—PPARG—respiratory system—lung cancer	0.000517	0.0719	CbGeAlD
Repaglinide—CYP2C8—mammary gland—lung cancer	0.000511	0.0711	CbGeAlD
Repaglinide—PPARG—epithelium—lung cancer	0.000432	0.0601	CbGeAlD
Repaglinide—PPARG—bone marrow—lung cancer	0.000303	0.0421	CbGeAlD
Repaglinide—PPARG—lung—lung cancer	0.000274	0.0382	CbGeAlD
Repaglinide—KCNJ11—lymph node—lung cancer	0.000267	0.0371	CbGeAlD
Repaglinide—Pruritus—Topotecan—lung cancer	0.000241	0.00128	CcSEcCtD
Repaglinide—Anaphylactic shock—Irinotecan—lung cancer	0.00024	0.00128	CcSEcCtD
Repaglinide—Oedema—Irinotecan—lung cancer	0.00024	0.00128	CcSEcCtD
Repaglinide—Malnutrition—Paclitaxel—lung cancer	0.00024	0.00128	CcSEcCtD
Repaglinide—Erythema—Paclitaxel—lung cancer	0.00024	0.00128	CcSEcCtD
Repaglinide—Diarrhoea—Vinblastine—lung cancer	0.00024	0.00128	CcSEcCtD
Repaglinide—Leukopenia—Cisplatin—lung cancer	0.000239	0.00127	CcSEcCtD
Repaglinide—Pruritus—Erlotinib—lung cancer	0.000238	0.00127	CcSEcCtD
Repaglinide—Gastrointestinal pain—Vinorelbine—lung cancer	0.000238	0.00127	CcSEcCtD
Repaglinide—Back pain—Etoposide—lung cancer	0.000237	0.00126	CcSEcCtD
Repaglinide—Thrombocytopenia—Irinotecan—lung cancer	0.000235	0.00125	CcSEcCtD
Repaglinide—Rhinitis—Docetaxel—lung cancer	0.000234	0.00125	CcSEcCtD
Repaglinide—Anaphylactic shock—Gemcitabine—lung cancer	0.000234	0.00125	CcSEcCtD
Repaglinide—Oedema—Gemcitabine—lung cancer	0.000234	0.00125	CcSEcCtD
Repaglinide—Hepatitis—Docetaxel—lung cancer	0.000234	0.00124	CcSEcCtD
Repaglinide—Diarrhoea—Topotecan—lung cancer	0.000233	0.00124	CcSEcCtD
Repaglinide—Cardiac failure congestive—Doxorubicin—lung cancer	0.000232	0.00124	CcSEcCtD
Repaglinide—Back pain—Paclitaxel—lung cancer	0.000232	0.00124	CcSEcCtD
Repaglinide—Urticaria—Vinorelbine—lung cancer	0.000231	0.00123	CcSEcCtD
Repaglinide—Diarrhoea—Erlotinib—lung cancer	0.00023	0.00123	CcSEcCtD
Repaglinide—Abdominal pain—Vinorelbine—lung cancer	0.00023	0.00123	CcSEcCtD
Repaglinide—Oedema peripheral—Docetaxel—lung cancer	0.00023	0.00123	CcSEcCtD
Repaglinide—Thrombocytopenia—Gemcitabine—lung cancer	0.000229	0.00122	CcSEcCtD
Repaglinide—Skin disorder—Gemcitabine—lung cancer	0.000227	0.00121	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000226	0.0012	CcSEcCtD
Repaglinide—Visual impairment—Docetaxel—lung cancer	0.000225	0.0012	CcSEcCtD
Repaglinide—Vomiting—Vinblastine—lung cancer	0.000223	0.00119	CcSEcCtD
Repaglinide—Erythema multiforme—Docetaxel—lung cancer	0.000221	0.00118	CcSEcCtD
Repaglinide—Headache—Vinblastine—lung cancer	0.000219	0.00117	CcSEcCtD
Repaglinide—Leukopenia—Etoposide—lung cancer	0.000219	0.00117	CcSEcCtD
Repaglinide—Eye disorder—Docetaxel—lung cancer	0.000218	0.00116	CcSEcCtD
Repaglinide—Anaphylactic shock—Cisplatin—lung cancer	0.000218	0.00116	CcSEcCtD
Repaglinide—Oedema—Cisplatin—lung cancer	0.000218	0.00116	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000218	0.00116	CcSEcCtD
Repaglinide—Cardiac disorder—Docetaxel—lung cancer	0.000217	0.00115	CcSEcCtD
Repaglinide—Vomiting—Topotecan—lung cancer	0.000216	0.00115	CcSEcCtD
Repaglinide—Hypoglycaemia—Doxorubicin—lung cancer	0.000216	0.00115	CcSEcCtD
Repaglinide—Paraesthesia—Irinotecan—lung cancer	0.000216	0.00115	CcSEcCtD
Repaglinide—Leukopenia—Paclitaxel—lung cancer	0.000215	0.00114	CcSEcCtD
Repaglinide—Rash—Topotecan—lung cancer	0.000215	0.00114	CcSEcCtD
Repaglinide—Hypersensitivity—Vinorelbine—lung cancer	0.000214	0.00114	CcSEcCtD
Repaglinide—Dermatitis—Topotecan—lung cancer	0.000214	0.00114	CcSEcCtD
Repaglinide—Vomiting—Erlotinib—lung cancer	0.000214	0.00114	CcSEcCtD
Repaglinide—Thrombocytopenia—Cisplatin—lung cancer	0.000213	0.00114	CcSEcCtD
Repaglinide—Headache—Topotecan—lung cancer	0.000213	0.00114	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000213	0.00113	CcSEcCtD
Repaglinide—Rash—Erlotinib—lung cancer	0.000212	0.00113	CcSEcCtD
Repaglinide—Dermatitis—Erlotinib—lung cancer	0.000212	0.00113	CcSEcCtD
Repaglinide—Palpitations—Paclitaxel—lung cancer	0.000212	0.00113	CcSEcCtD
Repaglinide—Skin disorder—Cisplatin—lung cancer	0.000212	0.00113	CcSEcCtD
Repaglinide—Dyspepsia—Irinotecan—lung cancer	0.000211	0.00113	CcSEcCtD
Repaglinide—Hypertension—Etoposide—lung cancer	0.000211	0.00112	CcSEcCtD
Repaglinide—Immune system disorder—Docetaxel—lung cancer	0.000211	0.00112	CcSEcCtD
Repaglinide—Headache—Erlotinib—lung cancer	0.000211	0.00112	CcSEcCtD
Repaglinide—Paraesthesia—Gemcitabine—lung cancer	0.00021	0.00112	CcSEcCtD
Repaglinide—Arrhythmia—Docetaxel—lung cancer	0.000209	0.00111	CcSEcCtD
Repaglinide—Chest pain—Etoposide—lung cancer	0.000208	0.00111	CcSEcCtD
Repaglinide—Nausea—Vinblastine—lung cancer	0.000208	0.00111	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000207	0.0011	CcSEcCtD
Repaglinide—Hypertension—Paclitaxel—lung cancer	0.000207	0.0011	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000207	0.0011	CcSEcCtD
Repaglinide—Alopecia—Docetaxel—lung cancer	0.000206	0.0011	CcSEcCtD
Repaglinide—Pancreatitis—Methotrexate—lung cancer	0.000206	0.0011	CcSEcCtD
Repaglinide—Pruritus—Vinorelbine—lung cancer	0.000206	0.0011	CcSEcCtD
Repaglinide—Constipation—Irinotecan—lung cancer	0.000205	0.00109	CcSEcCtD
Repaglinide—Arthralgia—Paclitaxel—lung cancer	0.000204	0.00109	CcSEcCtD
Repaglinide—Chest pain—Paclitaxel—lung cancer	0.000204	0.00109	CcSEcCtD
Repaglinide—Malnutrition—Docetaxel—lung cancer	0.000203	0.00108	CcSEcCtD
Repaglinide—Erythema—Docetaxel—lung cancer	0.000203	0.00108	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000203	0.00108	CcSEcCtD
Repaglinide—Nausea—Topotecan—lung cancer	0.000202	0.00108	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000202	0.00108	CcSEcCtD
Repaglinide—Constipation—Gemcitabine—lung cancer	0.0002	0.00106	CcSEcCtD
Repaglinide—Nausea—Erlotinib—lung cancer	0.0002	0.00106	CcSEcCtD
Repaglinide—Anaphylactic shock—Etoposide—lung cancer	0.0002	0.00106	CcSEcCtD
Repaglinide—Diarrhoea—Vinorelbine—lung cancer	0.000199	0.00106	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000199	0.00106	CcSEcCtD
Repaglinide—Back pain—Docetaxel—lung cancer	0.000197	0.00105	CcSEcCtD
Repaglinide—Gastrointestinal pain—Irinotecan—lung cancer	0.000196	0.00105	CcSEcCtD
Repaglinide—Oedema—Paclitaxel—lung cancer	0.000196	0.00104	CcSEcCtD
Repaglinide—Anaphylactic shock—Paclitaxel—lung cancer	0.000196	0.00104	CcSEcCtD
Repaglinide—Paraesthesia—Cisplatin—lung cancer	0.000196	0.00104	CcSEcCtD
Repaglinide—Thrombocytopenia—Etoposide—lung cancer	0.000196	0.00104	CcSEcCtD
Repaglinide—Skin disorder—Etoposide—lung cancer	0.000194	0.00103	CcSEcCtD
Repaglinide—Thrombocytopenia—Paclitaxel—lung cancer	0.000192	0.00102	CcSEcCtD
Repaglinide—Skin disorder—Paclitaxel—lung cancer	0.00019	0.00101	CcSEcCtD
Repaglinide—Abdominal pain—Irinotecan—lung cancer	0.00019	0.00101	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000188	0.001	CcSEcCtD
Repaglinide—PPARG—lymph node—lung cancer	0.000188	0.0261	CbGeAlD
Repaglinide—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000186	0.00099	CcSEcCtD
Repaglinide—Vomiting—Vinorelbine—lung cancer	0.000185	0.000986	CcSEcCtD
Repaglinide—Rash—Vinorelbine—lung cancer	0.000184	0.000977	CcSEcCtD
Repaglinide—Dermatitis—Vinorelbine—lung cancer	0.000183	0.000977	CcSEcCtD
Repaglinide—Headache—Vinorelbine—lung cancer	0.000182	0.000971	CcSEcCtD
Repaglinide—Leukopenia—Docetaxel—lung cancer	0.000182	0.000969	CcSEcCtD
Repaglinide—Palpitations—Docetaxel—lung cancer	0.00018	0.000957	CcSEcCtD
Repaglinide—Paraesthesia—Etoposide—lung cancer	0.000179	0.000955	CcSEcCtD
Repaglinide—Pancreatitis—Doxorubicin—lung cancer	0.000179	0.000951	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000178	0.00095	CcSEcCtD
Repaglinide—Angina pectoris—Doxorubicin—lung cancer	0.000177	0.000945	CcSEcCtD
Repaglinide—Hepatobiliary disease—Methotrexate—lung cancer	0.000177	0.000945	CcSEcCtD
Repaglinide—Hypersensitivity—Irinotecan—lung cancer	0.000177	0.000942	CcSEcCtD
Repaglinide—ALB—lymph node—lung cancer	0.000176	0.0245	CbGeAlD
Repaglinide—Paraesthesia—Paclitaxel—lung cancer	0.000176	0.000936	CcSEcCtD
Repaglinide—Hypertension—Docetaxel—lung cancer	0.000176	0.000935	CcSEcCtD
Repaglinide—Bronchitis—Doxorubicin—lung cancer	0.000175	0.000933	CcSEcCtD
Repaglinide—Arthralgia—Docetaxel—lung cancer	0.000173	0.000922	CcSEcCtD
Repaglinide—Chest pain—Docetaxel—lung cancer	0.000173	0.000922	CcSEcCtD
Repaglinide—Nausea—Vinorelbine—lung cancer	0.000173	0.000921	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Etoposide—lung cancer	0.000172	0.000918	CcSEcCtD
Repaglinide—Dyspepsia—Paclitaxel—lung cancer	0.000172	0.000918	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000172	0.000916	CcSEcCtD
Repaglinide—Constipation—Etoposide—lung cancer	0.000171	0.000909	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000169	0.0009	CcSEcCtD
Repaglinide—Hepatitis—Methotrexate—lung cancer	0.000168	0.000897	CcSEcCtD
Repaglinide—Constipation—Paclitaxel—lung cancer	0.000167	0.000892	CcSEcCtD
Repaglinide—Anaphylactic shock—Docetaxel—lung cancer	0.000166	0.000884	CcSEcCtD
Repaglinide—Oedema—Docetaxel—lung cancer	0.000166	0.000884	CcSEcCtD
Repaglinide—Pruritus—Gemcitabine—lung cancer	0.000165	0.000881	CcSEcCtD
Repaglinide—Hyperglycaemia—Doxorubicin—lung cancer	0.000164	0.000875	CcSEcCtD
Repaglinide—Diarrhoea—Irinotecan—lung cancer	0.000164	0.000875	CcSEcCtD
Repaglinide—Gastrointestinal pain—Etoposide—lung cancer	0.000163	0.00087	CcSEcCtD
Repaglinide—Thrombocytopenia—Docetaxel—lung cancer	0.000162	0.000865	CcSEcCtD
Repaglinide—Visual impairment—Methotrexate—lung cancer	0.000162	0.000864	CcSEcCtD
Repaglinide—Skin disorder—Docetaxel—lung cancer	0.000161	0.000858	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000161	0.000857	CcSEcCtD
Repaglinide—Hypersensitivity—Cisplatin—lung cancer	0.000161	0.000855	CcSEcCtD
Repaglinide—Gastrointestinal pain—Paclitaxel—lung cancer	0.00016	0.000853	CcSEcCtD
Repaglinide—Diarrhoea—Gemcitabine—lung cancer	0.00016	0.000852	CcSEcCtD
Repaglinide—Erythema multiforme—Methotrexate—lung cancer	0.000159	0.000848	CcSEcCtD
Repaglinide—Urticaria—Etoposide—lung cancer	0.000159	0.000845	CcSEcCtD
Repaglinide—Jaundice—Doxorubicin—lung cancer	0.000158	0.000843	CcSEcCtD
Repaglinide—Abdominal pain—Etoposide—lung cancer	0.000158	0.000841	CcSEcCtD
Repaglinide—Urinary tract infection—Doxorubicin—lung cancer	0.000158	0.000841	CcSEcCtD
Repaglinide—Eye disorder—Methotrexate—lung cancer	0.000157	0.000838	CcSEcCtD
Repaglinide—Cardiac disorder—Methotrexate—lung cancer	0.000156	0.000832	CcSEcCtD
Repaglinide—Urticaria—Paclitaxel—lung cancer	0.000156	0.000828	CcSEcCtD
Repaglinide—Abdominal pain—Paclitaxel—lung cancer	0.000155	0.000824	CcSEcCtD
Repaglinide—Hepatobiliary disease—Doxorubicin—lung cancer	0.000154	0.000818	CcSEcCtD
Repaglinide—Vomiting—Irinotecan—lung cancer	0.000153	0.000813	CcSEcCtD
Repaglinide—Sinusitis—Doxorubicin—lung cancer	0.000152	0.000811	CcSEcCtD
Repaglinide—Immune system disorder—Methotrexate—lung cancer	0.000152	0.00081	CcSEcCtD
Repaglinide—Rash—Irinotecan—lung cancer	0.000151	0.000806	CcSEcCtD
Repaglinide—Dermatitis—Irinotecan—lung cancer	0.000151	0.000805	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000151	0.000805	CcSEcCtD
Repaglinide—Headache—Irinotecan—lung cancer	0.00015	0.000801	CcSEcCtD
Repaglinide—Diarrhoea—Cisplatin—lung cancer	0.000149	0.000794	CcSEcCtD
Repaglinide—Paraesthesia—Docetaxel—lung cancer	0.000149	0.000794	CcSEcCtD
Repaglinide—Alopecia—Methotrexate—lung cancer	0.000149	0.000792	CcSEcCtD
Repaglinide—Vomiting—Gemcitabine—lung cancer	0.000149	0.000792	CcSEcCtD
Repaglinide—Rash—Gemcitabine—lung cancer	0.000147	0.000785	CcSEcCtD
Repaglinide—Dermatitis—Gemcitabine—lung cancer	0.000147	0.000785	CcSEcCtD
Repaglinide—Hypersensitivity—Etoposide—lung cancer	0.000147	0.000784	CcSEcCtD
Repaglinide—Malnutrition—Methotrexate—lung cancer	0.000147	0.00078	CcSEcCtD
Repaglinide—Erythema—Methotrexate—lung cancer	0.000147	0.00078	CcSEcCtD
Repaglinide—Headache—Gemcitabine—lung cancer	0.000146	0.00078	CcSEcCtD
Repaglinide—Rhinitis—Doxorubicin—lung cancer	0.000146	0.000778	CcSEcCtD
Repaglinide—Dyspepsia—Docetaxel—lung cancer	0.000146	0.000778	CcSEcCtD
Repaglinide—Hepatitis—Doxorubicin—lung cancer	0.000146	0.000776	CcSEcCtD
Repaglinide—Hypersensitivity—Paclitaxel—lung cancer	0.000144	0.000768	CcSEcCtD
Repaglinide—Oedema peripheral—Doxorubicin—lung cancer	0.000144	0.000765	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000143	0.000763	CcSEcCtD
Repaglinide—Nausea—Irinotecan—lung cancer	0.000143	0.000759	CcSEcCtD
Repaglinide—Constipation—Docetaxel—lung cancer	0.000142	0.000756	CcSEcCtD
Repaglinide—Back pain—Methotrexate—lung cancer	0.000142	0.000755	CcSEcCtD
Repaglinide—Pruritus—Etoposide—lung cancer	0.000141	0.000752	CcSEcCtD
Repaglinide—Visual impairment—Doxorubicin—lung cancer	0.00014	0.000748	CcSEcCtD
Repaglinide—Nausea—Gemcitabine—lung cancer	0.000139	0.00074	CcSEcCtD
Repaglinide—Vomiting—Cisplatin—lung cancer	0.000139	0.000738	CcSEcCtD
Repaglinide—Pruritus—Paclitaxel—lung cancer	0.000139	0.000738	CcSEcCtD
Repaglinide—Erythema multiforme—Doxorubicin—lung cancer	0.000138	0.000734	CcSEcCtD
Repaglinide—Rash—Cisplatin—lung cancer	0.000137	0.000732	CcSEcCtD
Repaglinide—Dermatitis—Cisplatin—lung cancer	0.000137	0.000731	CcSEcCtD
Repaglinide—Diarrhoea—Etoposide—lung cancer	0.000137	0.000728	CcSEcCtD
Repaglinide—Eye disorder—Doxorubicin—lung cancer	0.000136	0.000726	CcSEcCtD
Repaglinide—Gastrointestinal pain—Docetaxel—lung cancer	0.000136	0.000723	CcSEcCtD
Repaglinide—Cardiac disorder—Doxorubicin—lung cancer	0.000135	0.000721	CcSEcCtD
Repaglinide—Diarrhoea—Paclitaxel—lung cancer	0.000134	0.000713	CcSEcCtD
Repaglinide—Immune system disorder—Doxorubicin—lung cancer	0.000132	0.000701	CcSEcCtD
Repaglinide—Abdominal pain—Docetaxel—lung cancer	0.000131	0.000699	CcSEcCtD
Repaglinide—Leukopenia—Methotrexate—lung cancer	0.000131	0.000699	CcSEcCtD
Repaglinide—Arrhythmia—Doxorubicin—lung cancer	0.00013	0.000694	CcSEcCtD
Repaglinide—Nausea—Cisplatin—lung cancer	0.000129	0.00069	CcSEcCtD
Repaglinide—Alopecia—Doxorubicin—lung cancer	0.000129	0.000686	CcSEcCtD
Repaglinide—Vomiting—Etoposide—lung cancer	0.000127	0.000676	CcSEcCtD
Repaglinide—Erythema—Doxorubicin—lung cancer	0.000127	0.000676	CcSEcCtD
Repaglinide—Malnutrition—Doxorubicin—lung cancer	0.000127	0.000676	CcSEcCtD
Repaglinide—Rash—Etoposide—lung cancer	0.000126	0.000671	CcSEcCtD
Repaglinide—Dermatitis—Etoposide—lung cancer	0.000126	0.00067	CcSEcCtD
Repaglinide—Headache—Etoposide—lung cancer	0.000125	0.000666	CcSEcCtD
Repaglinide—Chest pain—Methotrexate—lung cancer	0.000125	0.000664	CcSEcCtD
Repaglinide—Arthralgia—Methotrexate—lung cancer	0.000125	0.000664	CcSEcCtD
Repaglinide—Vomiting—Paclitaxel—lung cancer	0.000124	0.000663	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000124	0.00066	CcSEcCtD
Repaglinide—Rash—Paclitaxel—lung cancer	0.000123	0.000657	CcSEcCtD
Repaglinide—Dermatitis—Paclitaxel—lung cancer	0.000123	0.000657	CcSEcCtD
Repaglinide—Back pain—Doxorubicin—lung cancer	0.000123	0.000654	CcSEcCtD
Repaglinide—Headache—Paclitaxel—lung cancer	0.000123	0.000653	CcSEcCtD
Repaglinide—Hypersensitivity—Docetaxel—lung cancer	0.000122	0.000651	CcSEcCtD
Repaglinide—Anaphylactic shock—Methotrexate—lung cancer	0.00012	0.000637	CcSEcCtD
Repaglinide—Nausea—Etoposide—lung cancer	0.000119	0.000632	CcSEcCtD
Repaglinide—Pruritus—Docetaxel—lung cancer	0.000117	0.000625	CcSEcCtD
Repaglinide—Thrombocytopenia—Methotrexate—lung cancer	0.000117	0.000624	CcSEcCtD
Repaglinide—Nausea—Paclitaxel—lung cancer	0.000116	0.000619	CcSEcCtD
Repaglinide—Skin disorder—Methotrexate—lung cancer	0.000116	0.000619	CcSEcCtD
Repaglinide—Leukopenia—Doxorubicin—lung cancer	0.000114	0.000605	CcSEcCtD
Repaglinide—Diarrhoea—Docetaxel—lung cancer	0.000114	0.000605	CcSEcCtD
Repaglinide—Palpitations—Doxorubicin—lung cancer	0.000112	0.000597	CcSEcCtD
Repaglinide—Hypertension—Doxorubicin—lung cancer	0.00011	0.000583	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000109	0.00058	CcSEcCtD
Repaglinide—Chest pain—Doxorubicin—lung cancer	0.000108	0.000575	CcSEcCtD
Repaglinide—Arthralgia—Doxorubicin—lung cancer	0.000108	0.000575	CcSEcCtD
Repaglinide—Paraesthesia—Methotrexate—lung cancer	0.000107	0.000572	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000107	0.000571	CcSEcCtD
Repaglinide—Vomiting—Docetaxel—lung cancer	0.000106	0.000562	CcSEcCtD
Repaglinide—Dyspepsia—Methotrexate—lung cancer	0.000105	0.000561	CcSEcCtD
Repaglinide—Rash—Docetaxel—lung cancer	0.000105	0.000557	CcSEcCtD
Repaglinide—Dermatitis—Docetaxel—lung cancer	0.000105	0.000557	CcSEcCtD
Repaglinide—Headache—Docetaxel—lung cancer	0.000104	0.000554	CcSEcCtD
Repaglinide—Anaphylactic shock—Doxorubicin—lung cancer	0.000104	0.000552	CcSEcCtD
Repaglinide—Oedema—Doxorubicin—lung cancer	0.000104	0.000552	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000103	0.00055	CcSEcCtD
Repaglinide—Thrombocytopenia—Doxorubicin—lung cancer	0.000101	0.00054	CcSEcCtD
Repaglinide—Skin disorder—Doxorubicin—lung cancer	0.000101	0.000536	CcSEcCtD
Repaglinide—Nausea—Docetaxel—lung cancer	9.86e-05	0.000525	CcSEcCtD
Repaglinide—Gastrointestinal pain—Methotrexate—lung cancer	9.78e-05	0.000521	CcSEcCtD
Repaglinide—Urticaria—Methotrexate—lung cancer	9.5e-05	0.000506	CcSEcCtD
Repaglinide—Abdominal pain—Methotrexate—lung cancer	9.45e-05	0.000504	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.44e-05	0.000503	CcSEcCtD
Repaglinide—Paraesthesia—Doxorubicin—lung cancer	9.3e-05	0.000495	CcSEcCtD
Repaglinide—Dyspepsia—Doxorubicin—lung cancer	9.12e-05	0.000486	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Doxorubicin—lung cancer	8.94e-05	0.000476	CcSEcCtD
Repaglinide—Constipation—Doxorubicin—lung cancer	8.86e-05	0.000472	CcSEcCtD
Repaglinide—Hypersensitivity—Methotrexate—lung cancer	8.81e-05	0.000469	CcSEcCtD
Repaglinide—Gastrointestinal pain—Doxorubicin—lung cancer	8.47e-05	0.000451	CcSEcCtD
Repaglinide—Pruritus—Methotrexate—lung cancer	8.46e-05	0.000451	CcSEcCtD
Repaglinide—Urticaria—Doxorubicin—lung cancer	8.23e-05	0.000438	CcSEcCtD
Repaglinide—Abdominal pain—Doxorubicin—lung cancer	8.19e-05	0.000436	CcSEcCtD
Repaglinide—Diarrhoea—Methotrexate—lung cancer	8.18e-05	0.000436	CcSEcCtD
Repaglinide—Hypersensitivity—Doxorubicin—lung cancer	7.63e-05	0.000406	CcSEcCtD
Repaglinide—Vomiting—Methotrexate—lung cancer	7.6e-05	0.000405	CcSEcCtD
Repaglinide—Rash—Methotrexate—lung cancer	7.54e-05	0.000402	CcSEcCtD
Repaglinide—Dermatitis—Methotrexate—lung cancer	7.53e-05	0.000401	CcSEcCtD
Repaglinide—Headache—Methotrexate—lung cancer	7.49e-05	0.000399	CcSEcCtD
Repaglinide—Pruritus—Doxorubicin—lung cancer	7.33e-05	0.00039	CcSEcCtD
Repaglinide—Nausea—Methotrexate—lung cancer	7.1e-05	0.000378	CcSEcCtD
Repaglinide—Diarrhoea—Doxorubicin—lung cancer	7.09e-05	0.000377	CcSEcCtD
Repaglinide—Vomiting—Doxorubicin—lung cancer	6.58e-05	0.000351	CcSEcCtD
Repaglinide—Rash—Doxorubicin—lung cancer	6.53e-05	0.000348	CcSEcCtD
Repaglinide—Dermatitis—Doxorubicin—lung cancer	6.52e-05	0.000347	CcSEcCtD
Repaglinide—Headache—Doxorubicin—lung cancer	6.49e-05	0.000346	CcSEcCtD
Repaglinide—Nausea—Doxorubicin—lung cancer	6.15e-05	0.000328	CcSEcCtD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.93e-05	0.000194	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	1.92e-05	0.000192	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—POMC—lung cancer	1.91e-05	0.000192	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTA4—lung cancer	1.91e-05	0.000192	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	1.9e-05	0.000191	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTA4—lung cancer	1.9e-05	0.000191	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	1.9e-05	0.000191	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.87e-05	0.000187	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—CREBBP—lung cancer	1.86e-05	0.000187	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTA2—lung cancer	1.86e-05	0.000187	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.86e-05	0.000186	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—POMC—lung cancer	1.85e-05	0.000186	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	1.85e-05	0.000186	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTA2—lung cancer	1.85e-05	0.000186	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—KRAS—lung cancer	1.84e-05	0.000185	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CYP1A1—lung cancer	1.84e-05	0.000184	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MMP1—lung cancer	1.83e-05	0.000183	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ERCC2—lung cancer	1.82e-05	0.000183	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CREBBP—lung cancer	1.81e-05	0.000181	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTA1—lung cancer	1.8e-05	0.00018	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—STK11—lung cancer	1.8e-05	0.00018	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTA1—lung cancer	1.79e-05	0.000179	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCC3—lung cancer	1.78e-05	0.000178	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCC3—lung cancer	1.77e-05	0.000177	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CD—lung cancer	1.77e-05	0.000177	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	1.75e-05	0.000176	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—APOA1—lung cancer	1.75e-05	0.000176	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—lung cancer	1.74e-05	0.000175	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLBD1—lung cancer	1.74e-05	0.000175	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1C1—lung cancer	1.72e-05	0.000173	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—CREBBP—lung cancer	1.72e-05	0.000172	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CD—lung cancer	1.71e-05	0.000172	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1C1—lung cancer	1.71e-05	0.000172	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—lung cancer	1.69e-05	0.00017	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.69e-05	0.000169	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—UGT1A1—lung cancer	1.67e-05	0.000168	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTP1—lung cancer	1.66e-05	0.000167	CbGpPWpGaD
Repaglinide—ALB—Metabolism—UGT1A1—lung cancer	1.66e-05	0.000167	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAT—lung cancer	1.62e-05	0.000162	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNG11—lung cancer	1.61e-05	0.000162	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.61e-05	0.000161	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.6e-05	0.000161	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNG11—lung cancer	1.6e-05	0.000161	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CG—lung cancer	1.6e-05	0.00016	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.59e-05	0.00016	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HSD17B10—lung cancer	1.59e-05	0.00016	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EGF—lung cancer	1.58e-05	0.000158	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOA1—lung cancer	1.58e-05	0.000158	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCB1—lung cancer	1.57e-05	0.000158	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—HRAS—lung cancer	1.56e-05	0.000157	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—TYMS—lung cancer	1.55e-05	0.000155	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CB—lung cancer	1.54e-05	0.000154	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALDOA—lung cancer	1.53e-05	0.000154	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—lung cancer	1.53e-05	0.000153	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—lung cancer	1.53e-05	0.000153	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALDOA—lung cancer	1.53e-05	0.000153	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.52e-05	0.000152	CbGpPWpGaD
Repaglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.51e-05	0.000151	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—lung cancer	1.5e-05	0.00015	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CB—lung cancer	1.49e-05	0.00015	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NCOA3—lung cancer	1.49e-05	0.000149	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CREBBP—lung cancer	1.48e-05	0.000149	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NCOA3—lung cancer	1.48e-05	0.000148	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CKB—lung cancer	1.48e-05	0.000148	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—lung cancer	1.48e-05	0.000148	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.46e-05	0.000147	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.45e-05	0.000146	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCG2—lung cancer	1.45e-05	0.000145	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ADCY1—lung cancer	1.45e-05	0.000145	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.45e-05	0.000145	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CYP1A1—lung cancer	1.45e-05	0.000145	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ADCY1—lung cancer	1.44e-05	0.000144	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCG2—lung cancer	1.44e-05	0.000144	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CG—lung cancer	1.44e-05	0.000144	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ERCC2—lung cancer	1.44e-05	0.000144	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HPGDS—lung cancer	1.42e-05	0.000142	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO2—lung cancer	1.42e-05	0.000142	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HPGDS—lung cancer	1.41e-05	0.000142	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO2—lung cancer	1.41e-05	0.000142	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.41e-05	0.000142	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CD—lung cancer	1.4e-05	0.000141	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPP2R1B—lung cancer	1.4e-05	0.000141	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.39e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CNDP2—lung cancer	1.39e-05	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM2—lung cancer	1.39e-05	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.38e-05	0.000139	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—lung cancer	1.38e-05	0.000139	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTT1—lung cancer	1.38e-05	0.000138	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—lung cancer	1.37e-05	0.000137	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTT1—lung cancer	1.37e-05	0.000137	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2A6—lung cancer	1.36e-05	0.000137	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCLC—lung cancer	1.36e-05	0.000137	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.36e-05	0.000136	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCLC—lung cancer	1.35e-05	0.000136	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2A6—lung cancer	1.35e-05	0.000136	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTMR3—lung cancer	1.35e-05	0.000136	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.35e-05	0.000135	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CREBBP—lung cancer	1.34e-05	0.000134	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTEN—lung cancer	1.33e-05	0.000133	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PGAM1—lung cancer	1.32e-05	0.000132	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ENO1—lung cancer	1.29e-05	0.000129	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTEN—lung cancer	1.29e-05	0.000129	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.29e-05	0.000129	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ENO1—lung cancer	1.28e-05	0.000129	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.28e-05	0.000129	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.28e-05	0.000128	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.27e-05	0.000127	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—EP300—lung cancer	1.27e-05	0.000127	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CD—lung cancer	1.27e-05	0.000127	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2A7—lung cancer	1.26e-05	0.000126	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RAF1—lung cancer	1.25e-05	0.000126	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—lung cancer	1.25e-05	0.000125	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOA1—lung cancer	1.24e-05	0.000125	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDC4—lung cancer	1.23e-05	0.000123	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—EP300—lung cancer	1.23e-05	0.000123	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CB—lung cancer	1.22e-05	0.000123	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.19e-05	0.000119	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.18e-05	0.000119	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2E1—lung cancer	1.16e-05	0.000116	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2E1—lung cancer	1.15e-05	0.000115	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NQO1—lung cancer	1.15e-05	0.000115	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NQO1—lung cancer	1.14e-05	0.000114	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—lung cancer	1.13e-05	0.000114	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IL2—lung cancer	1.12e-05	0.000113	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—RRM1—lung cancer	1.12e-05	0.000112	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTA3—lung cancer	1.12e-05	0.000112	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.12e-05	0.000112	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.11e-05	0.000112	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.11e-05	0.000111	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.1e-05	0.000111	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CB—lung cancer	1.1e-05	0.000111	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—lung cancer	1.09e-05	0.00011	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.09e-05	0.000109	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—lung cancer	1.08e-05	0.000108	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—B4GALT5—lung cancer	1.05e-05	0.000106	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CREBBP—lung cancer	1.05e-05	0.000105	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—lung cancer	1.05e-05	0.000105	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STK11—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STK11—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTA4—lung cancer	1.03e-05	0.000103	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—lung cancer	1.02e-05	0.000102	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—EP300—lung cancer	1.01e-05	0.000101	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTA2—lung cancer	1e-05	0.0001	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CD—lung cancer	9.97e-06	0.0001	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—lung cancer	9.84e-06	9.87e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SRC—lung cancer	9.81e-06	9.84e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.69e-06	9.71e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTA1—lung cancer	9.65e-06	9.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.63e-06	9.66e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—lung cancer	9.56e-06	9.58e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTP1—lung cancer	9.55e-06	9.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCC3—lung cancer	9.54e-06	9.56e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTEN—lung cancer	9.54e-06	9.56e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTP1—lung cancer	9.5e-06	9.52e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NRAS—lung cancer	9.44e-06	9.47e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—lung cancer	9.39e-06	9.41e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAT—lung cancer	9.29e-06	9.32e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAT—lung cancer	9.24e-06	9.27e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.24e-06	9.26e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1C1—lung cancer	9.24e-06	9.26e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.19e-06	9.21e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—lung cancer	9.1e-06	9.13e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—EP300—lung cancer	9.09e-06	9.12e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—lung cancer	9.04e-06	9.07e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCB1—lung cancer	9.04e-06	9.06e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCB1—lung cancer	8.99e-06	9.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UGT1A1—lung cancer	8.97e-06	8.99e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—TYMS—lung cancer	8.88e-06	8.9e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—TYMS—lung cancer	8.83e-06	8.85e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—lung cancer	8.78e-06	8.8e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—lung cancer	8.73e-06	8.75e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CB—lung cancer	8.69e-06	8.71e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNG11—lung cancer	8.65e-06	8.67e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—lung cancer	8.61e-06	8.63e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP1A1—lung cancer	8.32e-06	8.34e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP1A1—lung cancer	8.27e-06	8.29e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ERCC2—lung cancer	8.25e-06	8.27e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALDOA—lung cancer	8.23e-06	8.26e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ERCC2—lung cancer	8.2e-06	8.23e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—KRAS—lung cancer	8.13e-06	8.15e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NCOA3—lung cancer	7.99e-06	8.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADCY1—lung cancer	7.78e-06	7.8e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG2—lung cancer	7.78e-06	7.8e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—lung cancer	7.67e-06	7.69e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO2—lung cancer	7.63e-06	7.65e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HPGDS—lung cancer	7.63e-06	7.65e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.58e-06	7.6e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTEN—lung cancer	7.51e-06	7.53e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—lung cancer	7.47e-06	7.49e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—lung cancer	7.44e-06	7.46e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTT1—lung cancer	7.4e-06	7.42e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCLC—lung cancer	7.31e-06	7.33e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2A6—lung cancer	7.31e-06	7.33e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TP53—lung cancer	7.22e-06	7.24e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—EP300—lung cancer	7.16e-06	7.18e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA1—lung cancer	7.14e-06	7.16e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA1—lung cancer	7.1e-06	7.12e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—lung cancer	7.07e-06	7.09e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ENO1—lung cancer	6.93e-06	6.95e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—HRAS—lung cancer	6.91e-06	6.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.84e-06	6.85e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.8e-06	6.81e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—lung cancer	6.73e-06	6.75e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—lung cancer	6.52e-06	6.53e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—lung cancer	6.48e-06	6.5e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2E1—lung cancer	6.22e-06	6.23e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—lung cancer	6.2e-06	6.22e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—lung cancer	6.17e-06	6.18e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NQO1—lung cancer	6.15e-06	6.16e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—lung cancer	6.1e-06	6.11e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CREBBP—lung cancer	6.04e-06	6.06e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CREBBP—lung cancer	6.01e-06	6.02e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CD—lung cancer	5.73e-06	5.74e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CD—lung cancer	5.7e-06	5.71e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—lung cancer	5.66e-06	5.67e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STK11—lung cancer	5.54e-06	5.56e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—lung cancer	5.5e-06	5.51e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—lung cancer	5.3e-06	5.31e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTP1—lung cancer	5.13e-06	5.14e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CB—lung cancer	4.99e-06	5.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAT—lung cancer	4.99e-06	5e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CB—lung cancer	4.97e-06	4.98e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—lung cancer	4.95e-06	4.96e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—lung cancer	4.92e-06	4.93e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCB1—lung cancer	4.85e-06	4.87e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—TYMS—lung cancer	4.77e-06	4.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—lung cancer	4.71e-06	4.72e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP1A1—lung cancer	4.47e-06	4.48e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ERCC2—lung cancer	4.43e-06	4.44e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—lung cancer	4.33e-06	4.34e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTEN—lung cancer	4.32e-06	4.33e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTEN—lung cancer	4.29e-06	4.3e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—EP300—lung cancer	4.12e-06	4.13e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—EP300—lung cancer	4.09e-06	4.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA1—lung cancer	3.83e-06	3.84e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—lung cancer	3.5e-06	3.51e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—lung cancer	3.33e-06	3.34e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CREBBP—lung cancer	3.24e-06	3.25e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CD—lung cancer	3.08e-06	3.08e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—lung cancer	3.04e-06	3.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—lung cancer	3.04e-06	3.04e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—lung cancer	3.03e-06	3.03e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CB—lung cancer	2.68e-06	2.69e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—lung cancer	2.66e-06	2.66e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—lung cancer	2.49e-06	2.49e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—lung cancer	2.47e-06	2.48e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTEN—lung cancer	2.32e-06	2.32e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—EP300—lung cancer	2.21e-06	2.21e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—lung cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—lung cancer	1.33e-06	1.34e-05	CbGpPWpGaD
